Ensign Group stock
Price history
+6.27% over the period1 year: from $177.30 (November 13, 2025) to $188.41 (November 13, 2026), +6.27%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 13, 2026 | $188.41 |
| October 30, 2026 | $181.52 |
| September 30, 2026 | $172.00 |
| August 31, 2026 | $172.26 |
| July 31, 2026 | $178.16 |
| June 30, 2026 | $160.30 |
| May 29, 2026 | $167.65 |
| April 30, 2026 | $186.69 |
| March 31, 2026 | $201.50 |
| February 27, 2026 | $214.17 |
| January 30, 2026 | $171.66 |
| December 31, 2025 | $174.20 |
| November 28, 2025 | $185.54 |
| November 13, 2025 | $177.30 |
At a glance
The company
Provides skilled nursing, senior living, and rehabilitative services across the United States
Latest results
Quarter to September 30, 2026 · EPS $2.03 (estimate $1.97)
Next event
TickerLandia's take on Ensign Group
- Pricier than usual relative to earnings: P/E on the latest fiscal year 32 vs a median of 24 over its last 10 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 29 vs 23 (+28%) in a group of 11.
- Strong point: Growth (78/100 in its group). Weak point: Dividend (31/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−13.57% from the 52-week high
Analysts · 5 analysts
Average target$220.00+16.77% vs. price
Buy 4 · Hold 1 · Sell 0 · Buy
TickerLandia Fingerprint: Ensign Group
Compared with similar companies: high growth, low dividend, and low profitability.
Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 883 North American stocks.
Pricehigh63
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 21.9 69 Price/book 4.21 62 P/E (trailing 12 months) 28.9 58 EV/EBITDA 20.6 71 Price/sales 1.88 55 Profitabilitylow31
How much it earns on revenue and capital.
Metric Value Position in group ROE 17.0% 55 ROA 5.5% 34 Gross margin 16.6% 8 Operating margin 8.6% 18 Net margin 6.9% 39 Earnings stabilityhigh64
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.3% 71 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 58 Growthhigh78
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +18.68% 87 Revenue growth (year over year) +17.33% 82 Earnings growth (year over year) +16.67% 66 Financial strengthhigh61
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 53.2 97 Net debt/EBITDAcounts in reverse: lower means more financial strength 3.22 39 Current ratio 1.21 61 Debt/equitycounts in reverse: lower means more financial strength 0.92 45 Dividendlow31
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 20 years 75 Dividend yield 0.1% 9 Payout ratio 3.9% 9 Market momentumaverage53
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (6 months) +4.20% 53 Relative strength (3 months) +6.84% 66 1-year return +6.27% 40 Distance from 200-day average +3.50% 52 Risklow37
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 31.8% 56 Beta (1 year) 0.00 17 Volatility (60 days) 29.4% 37
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Ensign Group is pricier than in the past and pricier than similar companies
On the latest fiscal year's earnings (2025), Ensign Group's P/E today is 32.3, above the median of its last 10 fiscal years (24.3; between 21.3 and 30.7 from 2016 to 2025). Ensign Group's P/E (trailing 12 months): 28.9, +28% against the median of a group of 11 similar companies (22.6).
Compared with 11 similar companies
| Metric | Ensign Group | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 28.9 | Middle | |
| Forward P/E | 21.9 | Middle | |
| Operating margin | 8.6% | Low | |
| ROE | 17.0% | Middle | |
| Debt/equity | 0.92 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Ensign Group. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$1.48B
Latest quarter · Q3 2026
Net income
$104.26M
Latest quarter · Q3 2026
Quarterly net margin
7.0%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $10.59B
- P/E
- 28.9
- EPS
- $6.72
- Volume
- 961.43K
- Daily trading
- €65.7M
- Dividend yield
- 0.14%
- Last ex-dividend on September 30, 2026
How Ensign Group is changing
All resultsRevenue grew 16.1% a year on average over the last 5 years
Operating margin fell from 9.8% to 8.4%
Profits turn into cash: free cash flow equal to 98% of net income
Returns
Ensign Group returns with dividends
$1,000 invested in Ensign Group 5 years ago, on November 15, 2021, would be worth $2,338 today with dividends reinvested: +133.84% in total, +18.54% per year. On price alone it would be $2,315 (+131.46%).
| Period | Ensign Group | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +8.74% | −3.12% | $1,087 |
| 6 months | +5.85% | +1.58% | $1,058 |
| Year to date | +8.16% | +10.46% | $1,082 |
| 1 year | +6.42% | +12.23% | $1,064 |
| 3 years | +84.34% | +71.41% | $1,843 |
| 5 years | +133.84% | +61.48% | $2,338 |
| 10 years | +860.61% | +249.40% | $9,606 |
Over the last 6 months it has done better than 33% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Ensign Group: technical analysis
Ensign Group shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 12.7% below its all-time closing high ($215.83, March 2, 2026).
- Trend
- No clear trend
- RSI (14 sessions)
- 60
- Between 30 and 70
- vs 200-session average
- +3.50%
Support and resistance
Price areas where Ensign Group has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$217.46+15.42%2 touches, last on March 2, 2026
- Resistance$203.99+8.27%2 touches, last on April 20, 2026
- Resistance$190.00+0.84%3 touches, last on November 5, 2026
- Last price$188.41
- Support$185.43−1.58%4 touches, last on August 20, 2026
- Support$180.87−4.00%5 touches, last on October 15, 2026
- Support$172.23−8.59%6 touches, last on August 4, 2026
Volatility and risk
Over the last year it has moved little with the S&P 500.
- Beta (1 year) vs S&P 500
- 0.00
- Volatility (60 sessions, annualised)
- 29.4%
- Largest fall in the last year
- −31.83%
Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Ensign Group: seasonality
Average monthly price change over 19 years
Over the last 19 years, the strongest month for Ensign Group has been November: +5.12% on average, positive in 13 years out of 18. The weakest has been April: −2.52% on average, positive in 7 years out of 19.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.89% | −0.80% | 8 of 19 |
| February | +3.02% | +3.51% | 10 of 19 |
| March | +3.88% | +5.00% | 13 of 19 |
| April | −2.52% | −0.53% | 7 of 19 |
| May | +3.90% | +3.38% | 13 of 19 |
| June | +3.59% | +4.17% | 12 of 19 |
| July | +4.47% | +4.35% | 15 of 19 |
| August | +1.41% | +1.07% | 10 of 19 |
| September | −0.47% | −0.57% | 8 of 19 |
| October | +2.21% | +3.58% | 12 of 19 |
| November | +5.12% | +4.66% | 13 of 18 |
| December | +1.46% | +2.73% | 11 of 19 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Ensign Group and its competitors
Based in San Juan Capistrano, California, The Ensign Group has existed since its incorporation in 1999. Its operations span skilled nursing, senior living and rehabilitation, delivered in facilities located in sixteen US states, from Alaska to South Carolina. Patients receiving long-term nursing support, many with chronic conditions or prolonged illness, form a core group, alongside older adults who need on-site dialysis, ventilator care or cardiac and pulmonary management.
- Headquarters
- San Juan Capistrano, United States
- Employees
- 46,000
- Founded
- 1999
- Chief executive
- Barry Port
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Ensign GroupENSG | $10.59B | 8.6% | 28.9 | +5.85% |
| DavitaDVA | $10.98B | 15.2% | 13.2 | −11.88% |
| Universal Health ServicesUHS | $11.19B | 10.9% | 8.12 | +13.48% |
| Encompass HealthEHC | $13.83B | 18.4% | 22.6 | +31.17% |
| Tenet HealthcareTHC | $22.76B | 19.1% | 8.37 | +46.04% |
| HCA HealthcareHCA | $104.25B | 15.3% | 16.6 | +16.73% |
Same industry or related industries, similar size. Compare Ensign Group with its competitors · Full profile
